Oral bromelain attenuates inflammation in an ovalbumin-induced murine model of asthma

Evidence-based Complementary and Alternative Medicine

Volumn 5, Issue 1, 2008, Pages 61-69

  Secor Jr , Eric R ^a,b   Carson IV, William F ^a   Singh, Anurag ^a   Pensa, Mellisa ^a   Guernsey, Linda A ^a   Schramm, Craig M ^a   Thrall, Roger S ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Airway inflammation; Asthma; CD19+ B Cells; CD8+ T Cells; Cysteine protease; Eosinophils; IL 13; Immuno modulation

Indexed keywords

BROMELAIN; INTERLEUKIN 13; INTERLEUKIN 5; METHACHOLINE; OVALBUMIN; PHOSPHATE BUFFERED SALINE;

AEROSOL; ALLERGIC AIRWAY DISEASE; ALLERGIC DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; B LYMPHOCYTE; C57BL 6 MOUSE; CD19+ B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; EOSINOPHIL; FEEDING; FEMALE; HISTOLOGY; INFLAMMATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; STATISTICAL SIGNIFICANCE; TH2 CELL;

EID: 39749102881     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nel110     Document Type: Article

References (43)

1. Mickleborough TD, Lindley MR, Ionescu AA, et al. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006;129:39-49.
2. Mickleborough TD. Dietary omega-3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma. J Asthma 2005;42:305-14.
3. Shaheen SO, Sterne JA, Thompson RL, et al. Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med 2001;164: 10 Pt 1:1823-8.
4. Devereux G, Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol 2005;115:1109-17; quiz 1118.
5. Spector SL, Surette ME. Diet and asthma: has the role of dietary lipids been overlooked in the management of asthma? Ann Allergy Asthma Immunol 2003;90:371-377; quiz 377-8, 421.
6. Brownie S. The development of the US and Australian dietary supplement regulations. What are the implications for product quality? Complement Ther Med 2005;13:191-8.
7. Hijazi N, Abalkhail B, Seaton A. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia. Thorax 2000;55:775-9.
8. Kaminogawa S, Nanno M. Modulation of immune functions by foods. Evid Based Complement Alternat Med 2004;1:241-50.
9. Barnes P, Powell-Griner E, McFann K, Nahin R. Complementary and alternative medicine use among adults: United States, 2002. In: NIH/NCCAM (Ed.). CDC Advance Data Report 2004.
10. Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Altern Med Rev 2001;6:20-47.
11. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 1998;3:11:511-4.
12. Patwardhan B, Gautam M. Botanical immunodrugs: scope and opportunities. Drug Discov Today 2005;10:495-502.
13. Guggi D, Bernkop-Schnurch A. Improved paracellular uptake by the combination of different types of permeation enhancers. Int J Pharm 2005;288:141-50.
14. Hale LP, Greer PK, Trinh CT, et al. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol 2005;116:135-42.
15. Shinto L, Calabrese C, Morris C, et al. Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths. J Altern Complement Med 2004;10:891-7.
16. Sprava L. Effect of phlogenzym in long-term treatment of patients with multiple sclerosis. Mialovyts'ka OA. 2003;Apr-Jun:109-13.
17. Bellavite P, Ortolani R, Conforti A. Immunology and homeopathy. 3. Experimental studies on animal models. Evid Based Complement Alternat Med 2006;3:171-86.
18. Mynott TL, Engwerda CR, Peek K. Component of bromelain. 2004, Mynott, TL: United States.
19. Mynott TL, Ladhams A, Scarmato P, et al. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J Immunol 1999;163:2568-75.
20. Munzig E, Eckert K, Harrach T, et al. Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells. FEBS Lett 1994;351:215-8.
21. Hale LP, Haynes BF. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 1992;149:3809-16.
22. Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol 2002;104:183-90.
23. Secor ER Jr, Carson WFt, Cloutier MM, et al. Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease. Cell Immunol 2005;237:68-75.
24. Yiamouyiannis CA, Schramm CM, Puddington L, et al. Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model. Am J Pathol 1999;154:1911-21.
25. Kabbur PM, Carson WFt, Guernsey L, et al. Interleukin-10 does not mediate inhalational tolerance in a chronic model of ovalbumin-induced allergic airway disease. Cell Immunol 2006;239:1:67-74.
26. Klein G, Kullich W, Schnitker J, et al. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 2006;24:25-30.
27. White RR, Crawley FE, Vellini M, et al. Bioavailability of 125I bromelain after oral administration to rats. Biopharm Drug Dispos 1988;9:397-403.
28. Castell JV, Friedrich G, Kuhn CS, et al. Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am J Physiol 1997;273: 1 Pt 1:G139-46.
29. Gaspani L, Limiroli E, Ferrario P, et al. In vivo and in vitro effects of bromelain on PGE(2) and SP concentrations in the inflammatory exudate in rats. Pharmacology 2002;65: 2:83-6.
30. Martynenko AV. Wobenzym in the combined pathogenetic therapy of chronic urethrogenic prostatitis. Lik Sprava 1998;6:118-20.
31. Gollin MA. New rules for natural products research. Nat Biotechnol 1999;17:921-2.
32. Crowley R, FitzGerald LH. The impact of cGMP compliance on consumer confidence in dietary supplement products. Toxicology 2006;221:9-16.
33. Larimore WL, O'Mathuna DP. Quality assessment programs for dietary supplements. Ann Pharmacother 2003;37:893-8.
34. Dogheim SM, Ashraf el MM, Alla SA, et al. Pesticides and heavy metals levels in Egyptian leafy vegetables and some aromatic medicinal plants. Food Addit Contam 2004;21:323-30.
35. Durgnat JM, Heuser J, Andrey D, et al. Quality and safety assessment of ginseng extracts by determination of the contents of pesticides and metals. Food Addit Contam 2005;22:1224-30.
36. Jiang B, Kronenberg F, Nuntanakorn P, et al. Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry. J Agric Food Chem 2006;54:3242-53.
37. Bratke K, Haupt F, Kuepper M, et al. Decrease of cytotoxic T cells in allergic asthma correlates with total serum immunglobulin E. Allergy 2006;61:1351-7.
38. Li J, Saito H, Crawford L, et al. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology 2005;114:386-96.
39. Saito H, Matsumoto K, Denburg AE, et al. Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency. J Immunol 2002;168:3017-23.
40. Wang Y, McCusker CT. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma. Clin Exp Allergy 2005;35:1104-11.
41. Ohkawara Y, Lei XF, Stampfli MR, et al. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 1997;16:510-20.
42. Stock P, DeKruyff RH, Umetsu DT. Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol 2006;6(1):12-16.
43. Vojdani A, Erde J. Regulatory T Cells, a potent immunoregulatory target for CAM researchers: modulating allergic and infectious disease pathology (II). Evid Based Complement Alternat Med 2006;3:209-15.